Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Apr 5;11(7):1900-1902.
doi: 10.18632/aging.101894.

IgE, α-Gal and atherosclerosis

Jeffrey M Wilson  1 , Coleen A McNamara  2 , Thomas A E Platts-Mills  1
Affiliations
Editorial

IgE, α-Gal and atherosclerosis

Jeffrey M Wilson et al. Aging (Albany NY). .
No abstract available

Keywords: Immunoglobulin E; atherosclerosis; galactose-alpha-1,3-galactose; red meat; risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed model to explain the relationship between IgE sensitization to α-Gal and CAD. The hypothesized relationship involves an interaction between a specific IgE immune response to α-Gal and dietary consumption of α-Gal-bearing glycolipids. (A) Representative depiction of a glycolipid with an α-Gal epitope. Such glycolipids are present in red blood cell membranes, muscle, fat and secretions of non-primate mammals. (B) Dietary lipids are absorbed through the intestinal epithelium and packaged into lipoprotein particles. Initially this involves chylomicrons before passing to smaller particles such as LDL or HDL that can subsequently deliver α-Gal epitopes to peripheral tissue where mast cells reside. Importantly, this can include mast cells within atherosclerotic plaques. (C) Specific IgE are bound to mast cells, including IgE specific to α-Gal, in subjects who are sensitized to the oligosaccharide, and thus α-Gal from dietary exposure could bind to and activate signal transduction via the high-affinity IgE receptor (Fc εR1). Relatively low levels of α-Gal exposure may be insufficient to induce mast cell degranulation, and thus not lead to overt allergic symptoms such as hives or anaphylaxis, but could nonetheless lead to chronic mast cell activation and pro-inflammatory effects.
See this image and copyright information in PMC

References

    1. Hansson GK, Hermansson A. Nat Immunol. 2011; 12:204–12. 10.1038/ni.2001 - DOI - PubMed
    1. Morris-Rosenfeld S, et al. Expert Rev Clin Immunol. 2014; 10:77–89. 10.1586/1744666X.2014.857602 - DOI - PMC - PubMed
    1. Sun J, et al. Nat Med. 2007; 13:719–24. 10.1038/nm1601 - DOI - PubMed
    1. Kounis NG, Hahalis G. Atherosclerosis. 2016; 251:498–500. 10.1016/j.atherosclerosis.2016.05.045 - DOI - PubMed
    1. Wilson JM, et al. Curr Allergy Asthma Rep. 2017; 17:8. 10.1007/s11882-017-0672-7 - DOI - PMC - PubMed

Publication types

Substances

Supplementary concepts